The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights

Published:2022-07 Issue:4 Volume:1877 Page:188737
ISSN:0304-419X
Container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

Author:

Halder Sushanta,Parte Seema,Kshirsagar Prakash,Muniyan Sakthivel,Nair Hareesh B.,Batra Surinder K.,Seshacharyulu Parthasarathy

Funder

National Institutes of Health

U.S. Department of Defense

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Oncology

Reference155 articles.

1. Phosphorylation of LIFR promotes prostate cancer progression by activating the AKT pathway;Shao;Cancer Lett.,2019

2. Leukemia inhibitory factor promotes castration-resistant prostate cancer and neuroendocrine differentiation by activated ZBTB46;Liu;Clin. Cancer Res.,2019

3. LIF signaling in stem cells and development;Onishi;Development,2015

4. Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration;Dziennis;Rev. Neurosci.,2008

5. Leukemia inhibitory factor: a potential biomarker and therapeutic target in pancreatic cancer;Wrona;Arch. Immunol. Ther. Exp.,2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics combined to investigate potential druggable therapeutic targets for stroke: A systematic Mendelian randomization study and transcriptome verification;Journal of Affective Disorders;2024-12

2. Mutations in LIFR rewire the JAK/STAT signaling pathway: A study unveiling mechanistic details of Stüve-Wiedemann syndrome;Computers in Biology and Medicine;2024-09

3. A mechanistic PK/PD model of AZD0171 (anti‐LIF) to support Phase II dose selection;CPT: Pharmacometrics & Systems Pharmacology;2024-07-23

4. Leukemia inhibitory factor (LIF) receptor amplifies pathogenic activation of fibroblasts in lung fibrosis;2024-05-23

5. COL5A2 drives regorafenib resistance-induced metastatic phenotype via reducing LIFR expression in hepatocellular carcinoma;Acta Biochimica et Biophysica Sinica;2024-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3